Cemtrex Inc 8-K, filed Nov 1, 2021
Cemtrex Inc (CETX)
About this 8-K
Cemtrex Inc filed this 8-K on November 1, 2021.
Items reported
- Item 3.01: Delisting notice or listing transfer
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) | (Commission File Number) |
(I.R.S. Employer Identification No.) |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s
telephone number, including area code:
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading symbol | Name of each exchange on which registered | ||
CURRENT REPORT ON FORM 8-K
Cemtrex, Inc.
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
On November 1, 2021, Cemtrex, Inc. (the “Company”) received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it has regained compliance with the audit committee composition requirements (Listing Rule, 5605(c)(4)), and the scheduled hearing before the Hearings Panel of Nasdaq on November 11, 2021, has been cancelled. The Company’s securities will continue to be listed and traded on The Nasdaq Stock Market.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
| Exhibit Number | Exhibit Title | |
| 99.9 | Notice of regained compliance of a Continued Listing Rule and notification of hearing cancellation from NASDAQ Dated November 1, 2021 | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| CEMTREX, INC. | ||
| Date: November 1, 2021 | By: | /s/ Saagar Govil |
| Saagar Govil | ||
| Chairman, President and Chief Executive Officer | ||
EXHIBIT 99.1
Sent via electronic delivery
November 1, 2021
Saagar Govil
CEO
Cemtrex Inc.
276 Greenpoint Ave
Bld. 8, Suite 208
Brooklyn, NY 11222
| RE: | Cemtrex Inc. (Symbols: CETX; CETXP) |
| Nasdaq Listing Qualifications Hearings | |
| Docket No. NQ 6458C-21 |
Dear Mr. Govil:
This is to advise you that we have been informed by Nasdaq Staff that Cemtrex Inc.’s (the “Company”) has regained compliance with Nasdaq’s audit committee requirements as set forth in Listing Rule 5605 (the “Rule”) within the terms of the cure period provided by Listing Rule 5605(c)(4), and that the Company is therefore in compliance with the Nasdaq Capital Market’s listing requirements. Consequently, the scheduled hearing before the Hearings Panel on November 11, 2021, has been cancelled. The Company’s securities will continue to be listed and traded on The Nasdaq Stock Market.
Should you have any questions, please do not hesitate to contact me at (301) 978-8416.
Sincerely,
Aravind
Menon
Hearings Advisor
Nasdaq Office of General Counsel